PharmTech News

Sep 06, 2018
By Pharmaceutical Technology Editors
Emergent BioSolutions is set to acquire Adapt Pharma, a pharmaceutical company focused on addressing the opioid overdose and addiction crisis, in a deal worth up to $735 million.
Sep 06, 2018
By Pharmaceutical Technology Editors
Research from the Perelman School of Medicine at the University of Pennsylvania suggests that a universal flu vaccine that protects people against most influenza strains is one step closer to reality.
Sep 04, 2018
By Pharmaceutical Technology Editors
A collaboration integrates Sartorius Stedim Biotech’s BIOSTAT STR bioreactors and Repligen’s XCell ATF cell-retention control technology to create simplified, scalable equipment for intensified cell culture.
Sep 04, 2018
By Pharmaceutical Technology Editors
Skin-focused company LEO Pharma acquired Bayer’s prescription treatment portfolio.
Sep 04, 2018
By Pharmaceutical Technology Editors
As it investigates the root cause of an impurity discovered in valsartan, FDA extends its studies to APIs with similar synthesis processes.
Aug 31, 2018
By Pharmaceutical Technology Editors
Alcami and the University of North Carolina Wilmington received a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals to prepare students for careers in pharmaceutical sciences.
Aug 30, 2018
By Pharmaceutical Technology Editors
Girish Malhotra argues in CPhI Annual Report that shorter approval times and financial incentives are needed to promote manufacturing improvements.
Aug 30, 2018
By Pharmaceutical Technology Editors
The European Commission (EC) has approved GlaxoSmithKline’s (GSK) Nucala (mepolizumab) as an add-on treatment for severe refractory eosinophilic asthma in pediatric patients six to 17 years old.
Aug 29, 2018
By Pharmaceutical Technology Editors
Bristol-Myers Squibb appointed a new executive vice-president and chief commercial officer from within the company, effective immediately.
Aug 29, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The company’s new electron microscopy and microanalysis solutions offer scientists enhanced research capabilities.
native1_300x100
lorem ipsum